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Endocrinologists apply the idea of feedback loops to explain how hormones regulate
certain bodily functions such as glucose metabolism. In particular, feedback loops focus
on the maintenance of the plasma concentrations of glucose within a narrow range.
Here, we put forward a different, organicist perspective on the endocrine regulation
of glycaemia, by relying on the pivotal concept of closure of constraints. From this
perspective, biological systems are understood as organized ones, which means that
they are constituted of a set of mutually dependent functional structures acting as
constraints, whose maintenance depends on their reciprocal interactions. Closure refers
specifically to the mutual dependence among functional constraints in an organism.
We show that, when compared to feedback loops, organizational closure can generate
much richer descriptions of the processes and constraints at play in the metabolism and
regulation of glycaemia, by making explicit the different hierarchical orders involved. We
expect that the proposed theoretical framework will open the way to the construction of
original mathematical models, which would provide a better understanding of endocrine
regulation from an organicist perspective.
Keywords: organicism, feedback loop, organizational closure, glycemia regulation, proof of concept (POC),
functional constraints
INTRODUCTION
In recent years, an increasing number of contributions in theoretical biology and philosophy have
been advocating an organicist perspective (Gilbert and Sarkar, 2000; Etxeberria and Umerez, 2006;
Soto and Sonnenschein, 2006; Moreno and Mossio, 2015; Soto and Sonnenschein, 2018). According
to organicism, theoretical and experimental biology – and notably physiology – should address
aspects of living systems in light of their integration into a coherent unit, understood as a natural
system endowed with a distinctive complexity1.
One of the fundamental notions of organicism is ‘organization,’ a concept more specific than
a mere synonym of ‘configuration’ or ‘arrangement,’ which relies on a rich theoretical tradition
1By ‘distinctive complexity’ we mean those aspects that are specific to living systems, notably linked to their functionality
(Longo et al., 2015). It refers to their proper “way of being.” Understanding biological complexity is therefore a central
task of biological research. Complexity should not be confused with notions as ‘complication,’ which has a rather negative
connotation and refers to aspects that might be difficult to access theoretically or experimentally, or both.
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inspired by the work of Kant (1790) and Bernard (1865) and
further developed in the 1960’s and 1970’s (Piaget, 1967; Rosen,
1972; Pattee, 1972; Varela et al., 1974; Gánti, 1975). We use
the term ‘organization’ to refer to a certain mode of interaction
between the parts of a system, distinctively realized by biological
organisms when compared to other kinds of natural systems or
to artifacts. In a first approximation (see Section “Organizational
Principles” for more details), organization refers to a regime
in which (1) a set of parts are related to each other so as to
constitute a system that displays both functional differentiation
and integration; (2) the activity of the whole system plays a role in
producing and maintaining its parts over time: organized systems
maintain themselves.
Although organicism is gaining momentum in the theoretical
literature, a wider reception in biology would be achieved
if its applications were shown to improve experimental and
modeling practices. In the context of the issue topic “Multilevel
Organization and Functional Integration in Organisms,” the
general objective of this investigation is to propose a “proof
of concept,” an illustration of how organicist – and more
precisely, organizational – principles can advantageously modify
biological modeling. We do so by focusing on a particular
case study: the regulation of plasma glucose concentrations
(glycemia) in mammals.
Our aim is to show that the representation of this
phenomenon substantially changes when shifting from a
standard characterization in terms of feedback loops to an
original one grounded in organizational principles. Feedback
loops are control devices that, although not specific to biology,
have become since the 1930’s an important tool in different areas
of biology (e.g., neurophysiology, see for instance Lorente de
Nó, 1934), often in association with the idea of homeostasis
(Cannon, 1929). Since then, they have been used to model and
understand dynamically stable situations in which the value of a
variable appears to be actively maintained within a given range
(Wiener, 1948).
Feedback loops also provide a useful description of certain
complex physiological control phenomena. In endocrinology,
the concept of negative feedback plays a central role in the
understanding of the maintenance of calcium and glucose plasma
concentrations within a narrow range (Widmaier, 1992; Wilkin,
1997; Mundy and Guise, 1999; Carmeliet et al., 2003). Positive
feedback also plays an important role in endocrinology although,
in contrast to the negative feedback, it is used to explain how
an effect is amplified by creating instability, such as the positive
oxytocin loop of parturition and the estrogen-triggered positive
feedback of ovulation (Higuchi and Okere, 2002; Russel et al.,
2003; Christian and Moenter, 2010).
In spite of their widespread and practical use in developing
dynamical models of how physiological variables are maintained
as stable, we claim that feedback loops might bring about a
weakening of biological explanation. In particular, the description
of glucose regulation – the phenomenon on which we focus
here – in terms of feedback has three main problematic
implications: first, it tends to neglect the nature of the relations
between the parts and their place within the whole organism;
second, it flattens the description of the system by overlooking
the various categories of objects in play as well as their
hierarchical relations; third, it is built on the relationship between
concentrations of glucose, insulin and glucagon, and does not
foster the inclusion of further factors involved in the regulation
of glucose metabolism, such as the nervous system and the gut.
In contrast, we posit that the organicist perspective promotes a
more specific understanding of how biological organisms realize
homeostatic behavior in relation to certain variables. Biological
homeostasis is derived from more fundamental organizational
principles and explained as a result of the regulatory capacity of a
functionally differentiated hierarchical biological organism.
It is worth underscoring that our goal here is not to
provide a full-fledged model of the regulation of blood glucose
concentration, although we do provide some preliminary
guidelines. Rather, we aim to show how organizational principles
allow us to take into account the characteristic complexity of
biological systems when focusing on a specific phenomenon and,
therefore, open the way to the elaboration of richer and more
appropriate models.
THE STANDARD REPRESENTATION OF
GLYCEMIA REGULATION: THE
FEEDBACK LOOP
The model of homeostasis through negative feedback has a
long history. It dates back to the introduction of the notion of
“conservation of the internal milieu” by Bernard (1865) in the
19th century and Cannon’s (1929) subsequent introduction of
the concept of homeostasis in the early 20th century. Negative
feedbacks were explicitly formalized by cybernetics (Wiener,
1948) and traditionally used in engineering in the 1960’s (see
Lewis, 1992, chapter 1). Standard accounts of feedback can also be
found in the classical literature of systems theory (see for example
Rosen, 1968, p. 37; Jones, 1973, p. 80).
A negative feedback describes phenomena in which the value
of the output of a system is used to modify the activity of the
system (the output “feeds back”) in such a way as to create a
loop that reduces fluctuations in the output itself, and to make
its value homeostatic within a specific range. According to Rosen
(1968, p. 37), a feedback loop is characterized by the presence
of a controller and a controlled system: “The relation of the
controller and the controlled system is the following: the inputs
to the controller are the original inputs to the system, together
with the outputs of the controlled system; and the inputs to the
controlled system are the outputs of the controller. Thus, in effect
the controlled system is supplied with a new input set, determined
partly by its own past activity; i.e., we have a system with a
feedback.” As mentioned, feedback loops are widely used to
model homeostasis in numerous biological fields. Although they
share the core idea, different models vary regarding the number
and kind of elements constituting the feedback system. In what
follows, we rely on a recent characterization provided by Modell
et al. (2015), which gives a general and complete description of
the feedback loop, and is considered as a standard for education
purposes in physiology. While most feedback models usually
focus on the relationship between a reduced set of variables, this
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FIGURE 1 | Representation of glycemia regulation in terms of a feedback loop. The regulated variable (glycemia) is represented by the bold circle. The functional
components involved in the feedback loop are represented by rectangular boxes indicating their localization in the organism. Blue arrows indicate interactions
between components. Red arrows indicate interactions (signals and metabolic processes) that, triggered by low glycemia, produce an increase in glucose
concentration. Green arrows decrease the glucose concentration as a response to high glycemia. The system feeds back into itself by sensing the value of glycemia,
which is the target of its regulatory activity. The feedback loop maintains the value of glycemia as homeostatic by modulating the release of insulin and glucagon on
the basis of the difference between the actual value and the normal range.
description has the advantage of making explicit all the elements
that are often left implicit.
There are five components that a system must contain in order
to realize a feedback loop and to maintain a target variable – the
“regulated” one – as homeostatic, i.e., within a specific interval
(see Figure 1). Paraphrasing Modell et al. (2015), these are:
(1) A device/mechanism that establishes the normal range (“set
point”) of values for the regulated variable;
(2) A sensor that measures the actual value of the regulated
variable and emits a sensory signal;
(3) A detector that compares the actual value (through the
sensory signal) with the normal range. The result of this
comparison is an error signal that is sent to the controller;
(4) A controller that interprets the error signal and
determines – through a control signal – the value of
the outputs of the effector;
(5) An effector that responds to the control signal and modifies
the value of the regulated variable.
As Modell et al. (2015, p. 261) explain: “Such a system operates
in a way that causes any change to the regulated variable, a
disturbance, to be countered by a change in the effector output to
restore the regulated variable toward its set point value. Systems
that behave in this way are said to be negative feedback systems.”
Let us apply this description to the case of glycemia regulation
and locate the components of the feedback loop within the
organism. The description of glycemia homeostasis should show
how the organism manages to maintain a steady supply of
glucose, regardless of whether it is feeding or fasting. Glucose,
the regulated variable, is the principal source of energy for the
organism in general, and particularly for the brain.
During fasting, the liver (the main effector) breaks down
stored glycogen, and glucose is secreted into the bloodstream.
The activity of the liver is modulated by hormones that,
in the terminology of feedback control, are said to carry
signals. Glucagon, a hormone produced by the pancreas,
increases glycogenolysis and the synthesis of glucose from
amino acids and lipids (gluconeogenesis) in the liver. In
turn, the increase of glycemia triggers in the pancreas the
release of insulin, the hormone that facilitates the entry of
glucose into the muscle compartment (the other effector)
where it is needed for physical activity and inhibits glucagon
secretion. Muscular uptake decreases glycemia, which induces
the pancreas to secrete more glucagon, and so forth (see
Figure 1). In this picture, that focuses on the role of
hormones in modulating the effectors’ activity, the role of
sensor is supposed to be played by chemosensors located in
the pancreas and hypothalamus, structures that also play the
role of controllers. In contrast, the detector is not clearly
distinguished and located; however, it is inferred to be located
in the pancreas. A very important point here is that the
rate of secretion of hormones, as well as their effect in
controlling glycemia, is not an “all or none” phenomenon.
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That is, glucose, insulin and glucagon are always present in
the bloodstream.
Feeding leads to the storage of glucose as glycogen. More
precisely, food intake, digestion and absorption increase glycemia
in the systemic circulation that reaches all organs; in particular,
the increase is massive in the portal blood that supplies the liver.
High glycemia is sensed by the pancreas that, by also playing the
role of detector and controller, triggers a response mediated by its
beta-cells. These cells release insulin into the bloodstream. Insulin
promotes the transport of glucose into cells, predominantly those
in skeletal muscle and adipose tissue (both tissues are effectors),
and its conversion into glycogen in these compartments as well
as in the liver. As a result, glycemia decreases.
In both situations, a negative feedback is said to occur between
low glycemia and insulin concentration, because pancreatic beta-
cells slow down the rate of insulin secretion when glycemia is
low, which results into the stabilization of glycemia at some low
concentration. Additionally, a second and simultaneous chain
of events takes place. Low glycemia, stabilized by the decreased
rate of insulin release, suppresses the inhibition of alpha-
cells, which increases the rate of glucagon release. Glucagon
promotes the hydrolysis of glycogen in the liver and release
of glucose in the blood, which increases glycemia. This set of
coupled processes generates a homeostatic situation, in which
glycemia is maintained within a viable range by compensating
for both decreases and increases of glycemia. During both
fasting and the intestinal absorption of sugars, the circularity
of glucose homeostasis is given by the fact that, starting from
normal glycemia, variation in glucose concentration results in
the restoration of normal glycemia. Modell’s description of the
feedback system now applied to the control of glycemia is shown
in Figure 1.
The diagrammatic representation of glycemia regulation in
terms of feedback loops serves the purpose of focusing on and
making explicit the circular relations between coupled variables
(the concentrations of glucose, insulin, and glucagon) that are
relevant to explain the homeostatic behavior of the organism, in
relation to one of these variables, namely, glycemia. The negative
feedback diagram provides a useful tool for global evaluation of
the ability of the organism to blunt the increase of blood glucose
concentrations after administering a glucose overload. Indeed,
the glucose tolerance test provides a measure of the ability of
the organism to regulate glycemia and thus to evaluate normalcy,
pre-diabetes and diabetes.
Yet, in spite of the descriptive role and clinical usefulness of
the feedback loop, we submit that such a representation does
not foster an adequate understanding of biological organization
because most functional, topological and hierarchical features of
the organism remain hidden. What is put forward is the relation
between variables, without revealing much about the complexity
of the organism that should be spelled out to better understand
how it controls its own glycemia.
We think that the inadequacy of feedback loops takes four
forms. First, they tend to favor the idea of a neat localization
of functional components. While it usually works for manmade
machines because their parts have been designed separately
and assembled, a neat localization applies much less clearly for
organisms, in which a given function can be jointly performed
by several components and a given component or structure can
perform different functions. In addition, some functions can be
distributed over the entire system and thus are non-localizable.
Second, feedback loops tend to represent the system as a flat chain
of interacting components. As the above diagram illustrates, the
system is described as a set of functional components realizing
a chain of steps, with no hierarchies or distinction of levels.
Although they perform different functions, each component
interacts in the same way with the following one in the chain,
by either activating or inhibiting its activity (be it through
a signal or not), following the kind of perturbation affecting
the system. In this respect, there seems to be – to use a
philosophical expression – only one kind of “causal relation”
at work in a feedback loop, which makes us claim that the
resulting representation flattens the characteristic complexity
of the system. Third, feedback loops do not foster the search
of additional components and variables that might play a role
in the homeostatic behavior. Of course, feedback diagrams
can be enriched by new empirical knowledge; yet, they focus
exclusively on the relation between several variables (in our
example, the concentration of glucose, glucagon and insulin)
so as to understand the stability of the variable of interest
(glucose). Accordingly, they ignore – and do not encourage
exploring – the relationship between these variables and other
physiological components which converge in diverse ways to
control the concentration of glucose. Fourth, a description in
terms of feedback assumes the existence of a value (or, more
precisely, an interval of values) to be kept stable – a set point –
without providing an explanation of how it is established or how
it can be modified.
The epistemological stance that lies behind these weaknesses,
we submit, is the classical cybernetic analogy between organisms
and machines, which are supposed to realize the same kind of
control capacities. Although some aspects of biological organisms
can certainly be described in a way commonly used to describe
machines, the analogy can be misleading in several ways as
it risks concealing crucial differences between the two classes
of systems. In particular, this holds for homeostasis, whose
description in terms of feedback emphasizes the common
capacity of organisms and machines to maintain a given variable
as stable while overlooking biological specificities. While in
machines homeostasis is a goal determined by an external
designer, in organisms it constitutes a means to achieve the
more fundamental goal to maintain oneself as alive. Contrary
to machines, organisms maintain some variables as stable only
insofar as this promotes their self-maintenance, which means not
only that homeostasis is achieved in a different way, but also
that alternative behaviors and variations can be observed in some
circumstances. In this respect, a fundamental difference between
organisms and machines points to the device that establishes the
normal range of the regulated variable. In machines the normal
range, set by the human designer, is recorded in some component
of the system, while in organisms, as mentioned above, it is
unclear what process sets the normal range (many biologists
would presumably appeal to evolution). Furthermore, it is highly
debatable whether the normal range is recorded in some specific
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component of the system (Fitzgerald and Bean, 2018). While
feedback loops are blind to these differences, we submit that the
organizational framework fosters a more adequate understanding
of organismal homeostasis (and specifically glucose homeostasis)
as a manifestation of distinctive biological capacities.
ORGANIZATIONAL PRINCIPLES
The theoretical framework built on the notion of organization
characterizes biological systems as autonomous, i.e., endowed
with the distinctive capability to constantly produce, transform,
repair and replace their own components, and maintain
themselves through exchanges of matter and energy with the
environment (Piaget, 1967; Rosen, 1972; Varela et al., 1974;
Kauffman, 2000; Moreno and Mossio, 2015). Unicellular and
multicellular autonomous systems locally oppose the increase of
entropy and the thermodynamic tendency toward equilibrium.
They maintain themselves in far-from-equilibrium conditions –
i.e., in highly improbable dynamic distributions of energy and
matter – by controlling the thermodynamic flow.
Biological control can be defined as the capacity to modify
the dynamics of a system toward a certain state (e.g., an enzyme
acting upon concentrations of metabolites, see Rosen, 1970;
Fell, 1997). It implies an asymmetry between the controller
and what is controlled2. In biological systems control is exerted
by molecular and supra-molecular structures (such as enzymes
or membranes), by cells, extracellular structures, tissues and
organs that are produced and maintained by the system itself.
These structures act as constraints on the thermodynamic flow.
A constraint is a structure that has a causal effect on a
process (or transformation) while being locally unaffected by
the process at the time-scale in which it takes place (Montévil
and Mossio, 2015). Constraints play the role of local boundary
conditions that enable specific processes to take place by reducing
their degrees of freedom3 (Pattee, 1972; Kauffman, 2000). By
doing so they locally channel the flux of energy and matter,
chemical reactions, etc. toward outcomes that can contribute
to the functioning of the system, and that would be extremely
improbable (or practically impossible) in the absence of such
constraints. A paradigmatic example of a biological constraint is
an enzyme that, by lowering the activation energy necessary for
a reaction, catalyzes it toward an otherwise improbable product,
which in turn can be employed to perform some functional
activity for the system. Another example is given by the structures
constituting the vascular system, which constrain the circulation
of oxygen to the neighborhood of cells, where it participates
in respiration. As a matter of fact, it has been argued that any
biological structure or part to which biologists ascribe a function
can be conceptualized as exerting a constraint on a process or
transformation (Mossio et al., 2009).
2By ‘asymmetry’ we mean here that control is not a mutual interaction between
entities, but a relation in which it is possible to distinguish between what acts and
what is acted upon.
3By ‘degree of freedom’ we mean the number of variables of a process that are free
to vary independently.
The specificity of living systems is that they are organized,
by which we mean that their constitutive constraints collectively
produce and maintain each other and, ultimately, the whole
system itself. The resulting organization realizes a distinctive
regime, called organizational closure or closure of constraints,
in which the very existence and activity of a set of constraints
depends on their mutual relations and interactions (Moreno and
Mossio, 2015; Montévil and Mossio, 2015). Unlike other natural
self-maintaining systems such as dissipative structures – which
are spontaneous, are mostly or fully determined by external
boundary conditions and emerge anew each time under specific
environmental conditions – living systems are historical and
vastly contribute to determine their own conditions of existence
(Mossio and Bich, 2017).
At the intracellular level, the coordinated activity of organized
constraints such as proteins, membranes and nucleic acids,
contributes to the realization and maintenance of the organized
system that contains them, by channeling the flow of matter
and energy necessary to build these components and to run
the internal processes of the system (Ruiz-Mirazo and Moreno,
2004). Multicellular systems, while constraining thermodynamic
processes to sustain their own metabolism, also exert control
upon the activity of the cells that constitute their tissues and
organs (Arnellos et al., 2014; Longo et al., 2015; Montévil et al.,
2016; Soto et al., 2016; Veloso, 2017; Bich et al., 2019). At
both organizational levels, the set of mutually dependent control
constraints is responsible for the realization of what we label the
first-order regime of closure4 (Figure 2A).
Yet the first-order regime is only one dimension of the living
organization. In fact, one of the distinctive features of biological
autonomous systems is their adaptivity, and in particular the
capacity to modify their own first-order regime in relation to
changes in internal needs and external conditions. Such a capacity
can take two main forms. On the one hand, the first-order regime,
while performing metabolic activity, exhibits some dynamic
stability that makes it capable of compensating as a network
for small perturbations, mostly stoichiometrically5 by means of
changes in concentrations (for example, by relying on the balance
between supply and demand of metabolites). In such cases the
network is maintained by the same attractor or shifts toward a
new one among those available (in case of multi-stable networks).
On the other hand, living systems possess a specialized
class of organized constraints (which means that they are also
maintained by the organism), that we label regulatory, that act as
higher-order controllers upon first-order constraints. Regulatory
constraints modulate the first-order regime of closure in response
to specific variations induced by external perturbations, but also
by internal dynamics of the organism (Bich et al., 2016). They
do so by selectively inducing shifts between distinct available
4The organizational framework considers that the hierarchies of levels and orders
are distinct. A ‘level’ designates a closed regime of constraints that is either made
of constituents, or included in an encompassing system, realizing themselves a
distinct closure. An ‘order,’ in turn, designates a kind of functional object that
operates over (modulates) other functional objects, within the same regime of
closure. See Moreno and Mossio (2015, p. 143) for details.
5That is, in terms of quantitative relationships between different compounds
involved in chemical reactions.
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FIGURE 2 | Representation of glycemia regulation in terms of organizational closure. (A) Represents the first-order functional regime, in which a set of functional
parts (rectangular boxes) constrain (blue arrows) processes and transformations (dotted blue arrows) involving glucose as a product or metabolite. Metabolic
substrates and products are in dotted circles. Constraints and processes in red and green are those that affect glucose and glucagon concentrations. Organizational
closure is realized by the fact that each part acting as a constraint is also the product of a metabolic process within the system. As a result, the system
self-maintains. (B) Includes second-order regulatory functions to organizational closure. The regulatory subsystem comprises parts which play the role of constraints
that are sensitive to glycemia (sensitivity to x is marked by <x>above the pertinent box) and second-order constraints (double arrows), which modulate the activity of
first-order ones. Regulatory constraints marked in red are sensitive to low glycemia and accelerate glycogenolysis; regulatory constraints marked in green are
sensitive to high glycemia and accelerate glycogenesis. The overall result of regulation is the homeostasis of glycemia, which is not represented as a separate
‘component’ in this figure, but constitutes an effect of the biological dynamics controlled and regulated by different orders of organized constraints. (C) Adds
third-order regulatory functions. The regulatory subsystem includes parts that play the role of constraints sensitive to food (either by ingestion or perception) and
exert third-order constraints (triple arrows) on second-order constraints. The inhibitory action of insulin on alpha-cells is also interpreted as a third-order constraint.
Second- and third-order regulatory constraints are also the target of metabolic processes, which contribute to their maintenance: therefore, the whole hierarchical
system realizes organizational closure.
physiological6 or agential regimes7. A typical example is the
regulation of the direction of movement in bacteria performing
chemotaxis, which depends on the sensing of sugar gradients
and is achieved by shifting the motion of the flagellum between
tumbling and rotating8. Another example of dynamics requiring
regulation is protein synthesis. Not all possible proteins can
be available simultaneously in the system, due to spatial and
energetic limitations; therefore, the various components should
be synthesized just when they are needed. Also, some subsystems
may work differently and with different requirements, not always
compatible, and their operations need to be modulated in such
a way that they can jointly contribute to the maintenance of the
system while avoiding potential conflicts (Bich, 2018)9.
Regulation provides the organism with the possibility of acting
upon its own dynamics. Conceptually, a regulatory subsystem
includes a set of dynamic constraints operating in a way that
6For example, diauxic shifts in the metabolism of bacteria between different carbon
sources, regulated by switching the genes involved in the synthesis of the relative
enzymes on and off.
7Autonomous agency can be defined as the set of activities that modify the
environment of the system that generates them and are “performed according to a
certain goal or norm” (Moreno, 2018, p. 290), which is related to the maintenance
of the system itself.
8See Bich and Moreno (2016) for an analysis of bacterial chemotaxis in terms of
regulatory constraints.
9For a discussion of the importance of regulation to understand life and its origins,
see also Cornish-Bowden and Cárdenas (2019).
is distinct from first-order constraints, and collectively satisfying
two main requirements:
(1) The presence of constraints that act as second-order
controllers, which means they modulate the activity
of other constraints in the system, instead of directly
channeling metabolic processes (which is what first-order
constraints do)10;
(2) The presence of constraints that, by being specifically
sensitive to variations in internal or external
conditions, begin to perform a qualitatively different
function and, thereby, bring about the activity of the
regulatory subsystem.
The first requirement implies that there is no regulation when
the change of first-order dynamics is not due to the action of
a constraint but, instead, to a variation in the concentration
of a metabolite, which changes the rates of the metabolic
pathways because of the effects of the law of mass action.
The second requirement, in turn, means that regulation is a
context-sensitive phenomenon, which is triggered by specific
conditions, as for example when an enzyme reacts to an
allosteric interaction. In particular, there must be constraints
that perform a function only when a given internal or external
10An example of a second-order constraint is a kinase enzyme catalyzing the
phosphorylation of another enzyme in the system, leading to the activation or
inhibition of the latter, while being locally unaffected by such interaction (for
example, the kinase is not consumed in the reaction).
Frontiers in Physiology | www.frontiersin.org 6 February 2020 | Volume 11 | Article 69
fphys-11-00069 February 15, 2020 Time: 17:3 # 7
Bich et al. Glucose Regulation and Organizational Closure
variable (to which they are “sensitive”) undergoes a specific
change11 (Figure 2B).
For regulation to be functional in the context of the
organism, there must be a connection between what stimulates
the regulatory subsystem and what this subsystem acts on.
It means that the regulatory action should make the first-
order dynamics viable in the context that activated regulation
in the first place. For instance, there is a relation between
blood glycemia and glycogenesis, so that a modulation of
the latter constitutes an adaptive response to the viability
challenge raised by a significant variation of the former. Yet,
this relation does not take the form of a direct dependence,
which means that variations of the conditions that activate
a sensitive constraint (e.g., through an allosteric interaction)
affect the subsystem differently than variations of the processes
on which second-order constraints exert their control12. This
asymmetrical relation is what we have referred to elsewhere
as “dynamical decoupling,” between regulatory and regulated
constraints (Bich et al., 2016), by which the regulatory subsystem
exhibits degrees of freedom that are not specified by the
dynamics of the regulated one. Such a local independence allows
regulatory subsystems to modulate first-order constraints in a
relatively autonomous way.
In brief, regulatory subsystems exhibit context-sensitive
activity13 that adaptively modulates metabolic processes by acting
upon first-order constraints. They act when specific conditions
are met, so as to maintain the overall viability of the system. Let
us apply these ideas to the case of glucose regulation.
REINTERPRETING GLUCOSE
REGULATION FROM ORGANIZATIONAL
PRINCIPLES
How do organizational principles guide the elaboration of a
biological model? To study a phenomenon, the organizational
framework requires the identification of the relevant processes,
the time scales at which they can be described, and the first-order
constraints acting upon them at those times scales. Once these
objects are identified, the next step consists of determining the
dependencies between the constraints so as to obtain a closed
graph, in which at least a subset of constraints are maintained
by processes under the control of other constraints, so that the
entire network can be said to realize collective self-maintenance.
Moreover, if the aim is to understand how this network of
constraints is modulated in response to external perturbations
11In this framework, biologically relevant entities can have a twofold role.
A molecule, for instance, can be characterized as a stimulus when, by interacting
with a sensitive constraint, induces the activation of the latter. The same molecule,
instead, can play the role of a metabolite when consumed as a substrate in a
metabolic process.
12This is exemplified by the kinases. Their activation is triggered by an interaction
on a different site than the active one that catalyzes the phosphorylation of other
enzymes. In this case, the regulatory subsystem is realized by a single enzyme. In
other cases, as we will discuss, the subsystem is constituted by a set of different
constraints playing different roles, and collectively realizing the regulation.
13On the biological importance of control constraints that exhibit context-sensitive
activity, see also Pattee (1972); Abel (2010), and Winning and Bechtel (2018).
or changes in the internal state of the system, second-order
dynamically decoupled constraints need to be identified and
integrated into the closed graph of dependencies14.
Let us illustrate how this general procedure can be
applied by considering the case of glycemia regulation in
multicellular systems, specifically mammals. Glucose as a
metabolite constitutes a primary energy source for these
organisms. The plasma concentration of glucose depends on
food uptake and on those internal metabolic processes (as
well as organismal activities, such as exercise) that consume,
transform, store and release this sugar. As shown in the feedback
loop diagram, glycemia is kept within a specific interval in the
blood despite variations affecting the supply and consumption of
glucose. From an organizational perspective, such a homeostatic
behavior is achieved through the contributions of both first-order
compensatory capacities and higher-order regulatory functions,
the latter ones involving different organs and resulting in the
modulation of the whole first-order metabolic regime.
To describe the regulation of glucose metabolism that
results in homeostasis, it is first necessary to identify the key
processes involving glucose as a metabolite and the first-order
constraints that control it. This first-order regime is a theoretical
extrapolation, because there is no real organism devoid of
regulatory constraints. However, experiments removing the
constraining action of insulin and glucagon in mice give us a
“real-life” approximation of how the first-order regime would
work in the absence of the main regulatory constraints (Unger
and Cherrington, 2012). As we will see, some of these first-
order constraints are responsible for the presence of glucose in
the blood, which makes it available to all cells, others for its
removal from the bloodstream for utilization or storage. Glucose
metabolism consists of different processes, which are:
(1) Glucose uptake by the cells of different tissues (brain,
intestine, liver, etc.), constrained by glucose transporters in
the cell membrane;
(2) Food intake, which includes the ingestion and digestion
of carbohydrates and drastically changes the amount of
glucose in the system. It is constrained by the digestive
system (its dynamic structural constraints, the digestive
enzymes and the absorption by the epithelial cells of the
intestine). Food intake is the main source of variation
for the first-order regime of utilization and production of
glucose;
(3) Intracellular glycolysis, the breaking down of glucose
molecules into pyruvate as part of the process of
production of ATP. This process is constrained by enzymes
in the cell metabolism;
(4) Glycogenesis, which consists of the transformation of
glucose into glycogen for storage: a process constrained
mainly by liver cells, striated muscles cells and cells of the
white adipose tissue in which it is then stored;
(5) Glycogenolysis, the transformation of stored glycogen into
glucose, constrained by all cells that store glycogen.
14Veloso (2017) provides a mathematical approach to detect regulatory decoupling
in the case of epigenetic control during the development of multicellular systems.
Frontiers in Physiology | www.frontiersin.org 7 February 2020 | Volume 11 | Article 69
fphys-11-00069 February 15, 2020 Time: 17:3 # 8
Bich et al. Glucose Regulation and Organizational Closure
Glycogenolysis by hepatic cells is the main source of blood
glucose during fasting;
(6) Gluconeogenesis, also constrained by liver cells, which
produce glucose anew starting from amino acids, lipids,
pyruvate and lactate;
(7) Glucose transport, responsible for the distribution of
glucose in the system: once this sugar reaches the
bloodstream (after its absorption in the intestine, or after its
secretion by the liver during fasting) its distribution in the
body is constrained by the vascular system (e.g., the portal
vein for transport to the liver, the hepatic veins for release
into the general circulation).
All the constraints acting on the previous processes (namely:
the digestive system, the vascular system and different organs
and cell types) are in turn maintained by the glucose supply
they constrain. By controlling processes involving glucose, they
therefore contribute to their own conditions of existence and
to the overall maintenance of the biological system that harbors
them. In sum, they contribute to the realization of a regime of
first-order closure (see Figure 2A).
How does the system manage changes in glucose
concentration? In basal conditions, in which there is neither
an abrupt intake nor a high need for glucose, the organism
is constantly subject to small variations in glycemia due to
stochastic interactions and the dynamic balance among the first
five coupled processes. This first-order regime exhibits dynamic
stability with respect to such variations mainly through a balance
of processes 4 (glycogenesis) and 5 (glycogenolysis), plus 3
(glycolysis)15. Supply and demand effects such as a small increase
in glucose concentrations in the blood, or of glycogen content
in the cells, can speed up, dampen or inhibit the processes
that rely on or produce these metabolites. For example, the
glycogenesis pathway in muscle cells is characterized by two
steps: the phosphorylation of glucose into G6P, constrained
by the transport/hexokinase (GT/HK) subsystem; and the
production of glycogen from G6P, constrained by the enzyme
glycogen synthase (GSase). Due to both allosteric interactions
and the effect of mass action, an increase in the supply of glucose
can favor these reactions, while the accumulation of glycogen in
turn inhibits the pathway. Because of these network properties
the first-order regime achieves – with no regulation in the
organizational sense – a balance that allows it to compensate for
small variations in glycemia and at the same time exert a tight
control upon this and other individual pathways (Figure 2A).
Such a delicate balance of first-order control mechanisms
is however insufficient to maintain glucose homeostasis in the
organism, both in basal conditions and – a fortiori – in response
to greater alterations of glycemia caused by food intake or
sudden high energy needs16. This is why regulatory constraints
intervene to selectively modulate the first-order constraints in
a coordinated way. By doing so, they allow the metabolism to
speed up glycogenesis and inhibit glycogenolysis in the presence
15Gluconeogenesis (process number 6) contributes to this balance during fasting,
exercise and when other sources are mostly depleted.
16Variations in glucose concentrations can only change glycogen production
linearly in the absence of a significant release of insulin (Schafer et al., 2005).
of high glucose concentrations, and vice versa in the case of low
concentrations. A central role in glucose regulation is played, as
discussed in Section “The Standard Representation of Glycemia
Regulation: The Feedback Loop,” by the hormones insulin and
glucagon released by the pancreas. From an organizational
perspective, they can be treated as second-order constraints that
modulate the functioning of other first-order constraints. Insulin
does so in three ways: it facilitates glucose uptake in muscle and
adipose tissue; it increases glycogenesis in liver, striate muscle and
white fat cells; and it inhibits glucagon secretion by pancreatic
alpha-cells. Glucagon, in turn, increases glycogenolysis and
gluconeogenesis in the liver, and thus the release of glucose in
the bloodstream.
Let us follow the conceptual scheme introduced at the end
of Section “Organizational Principles” and focus first on the
activation of the regulatory subsystem. Pancreatic beta-cells
continuously produce and store insulin in vesicles and secrete it
into the bloodstream. The secretion of insulin occurs when the
insulin containing vesicles already present in the cells fuse with
the cell membrane and release the hormone. In basal conditions,
the release of insulin is low, but when the glycemia rises, beta-
cells secrete it abundantly, thus modulating the metabolic activity
of the first-order regime. Note that the activation of regulation is
independent of insulin synthesis and the subsequent glycolysis,
which is consistent the idea of dynamical decoupling discussed
above. As a matter of fact, as we discuss just below, the activation
does not even depend directly on glucose, but rather on the
capacity of the regulatory subsystems within these cells to sense
the energetic state of the intracellular metabolism.
As discussed in the previous Section, the regulatory subsystem
includes two fundamental functional parts: the second-order
constraints and the sensitive constraints (Figure 2B). From
the organizational perspective, the elaboration of the model
should therefore identify the parts that perform these functions.
What are the sensitive constraints in this case? When glucose
circulating in the blood is transported into beta-cells, it is
metabolized and transformed into ATP. The increase in the
ratio between ATP and ADP triggers a sequence of changes in
some of the constraints in the cells (ion channels and membrane
polarity), starting from the closing of ATP-sensitive K+-channels
and the consequent depolarization of the membrane. The
depolarization of the membrane is followed by the opening of
voltage-dependent calcium ions channels. The channels opening
activates the proteins of the SNARE17 complex of the membrane,
which in turn controls the fusion of the membrane and the
vesicles containing insulin, with the consequent release of this
hormone in the bloodstream (see for example Röder et al.,
2016). We submit that the channels are the best candidate
to be understood as the sensitive constraints of the glycemia
regulatory subsystem: they convert a quantitative change in the
cellular metabolism (increased production of ATP) – induced
by an increase of glycemia – into a qualitative change in the
regulatory subsystem (the closing of the K + -channels and
17SNARE (SNAP receptor) is an acronym designating a group of proteins that
mediate membrane fusion and exocytosis. SNAP is an acronym for Soluble NSF
(N-ethylmaleimide-sensitive factor) attachment proteins.
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the depolarization of the membrane)18. From this point on,
the activation state of the regulatory subsystem results into the
release of the second-order constraint (insulin) through a series
of intermediate steps involving changes in potential. Glucagon
secretion by pancreatic alpha-cells is activated in a similar way
through the calcium-mediated fusion of glucagon-containing
vesicles with the cell membrane, controlled by the SNARE
complex. Yet, activation in alpha- and beta-cells is triggered
by opposite glucose concentrations because of the specificity
of their sensitive constraints (the ion channels). In alpha-cells,
activation is triggered by cAMP19 when glucose concentration,
and consequently that of ATP, is low (Gaisano et al., 2012).
With regard to the second-order action of the regulatory
constraints, insulin plays three functional roles: (1) it facilitates
glucose uptake into cells of muscle and adipose tissues, (2) it
stimulates glycogenesis and (3) it inhibits the release of glucagon
by pancreatic alpha-cells and, consequently, glycogenolysis.
The first function is exerted by facilitating the migration of
the glucose transporter GLUT4 to the plasma membrane by
stimulating the glucose transport/hexokinase (GT/HK) first-
order constraints. The second function is exerted by directly
controlling those first-order constraints responsible for the
process of production of glycogen from glucose through the
phosphorylation of the enzyme glycogen synthase (GSase). The
third function of insulin is to inhibit the production of glucose
from glycogen (glycogenolysis) by liver cells, by activating
phosphoprotein phosphatases 1 (PP1), which dephosphorylate
glycogen phosphorylase, thus inhibiting its activity (Hye-Sook
et al., 2016), and by inhibiting the release of glucagon by alpha-
cells. The later effect on alpha-cells occurs by modifying one of
the first-order constraints involved, the membrane potential of
alpha-cells (see for example Quesada et al., 2008).
The secretion by alpha-cells of glucagon, the other second-
order regulatory constraint, is markedly increased when glycemia
is low. In this circumstance insulin release is strongly decreased,
and the intracellular ATP concentration in alpha-cells is low,
while cAMP concentration is increased. Glucagon triggers a
cascade of phosphorylation in liver cells, activating the enzymes
(first-order constraints) responsible for glycogenolysis, which
is the transformation of glycogen back to glucose. In addition
to the increase of glucagon secretion triggered directly by
hypoglycemia, there is a counterintuitive increase of glucagon
triggered by hyperglycemia. This effect manifests spontaneously
when there is a severe loss of beta-cells in diabetes type-I,
because insulin secreted in paracrine fashion normally inhibits,
as mentioned, the release of glucagon by the alpha-cells adjacent
to beta-cells. However, it has been recently postulated that
prior to the destruction of beta-cells in diabetes type I an
18It is important to point out that glucose is part of the metabolic process
constrained by first-order constraints, in this specific case the enzyme glucokinase,
which catalyzes the same process in a multitude of different cell types. The sensitive
constraint belonging to the regulatory subsystem should not be part of the process
or the first-order constraint, but should bring forth a qualitative change. In our
proposal this corresponds to the ion channel. Regulation is activated in beta-cells
with the polarization of the membrane, a qualitative change that is not metabolic
anymore and which for example does not take place in other types of cells.
19Cyclic adenosine monophosphate (cAMP), obtained from ATP, is a second
messenger involved in various physiological processes. The activation of glucagon
secretion in alpha-cells is triggered by cAMP when ATP concentration is low.
increased glucagon concentration is observed and is attributed
to hyperglycemia. Such an effect of hyperglycemia on glucagon
release could be obtained experimentally in normal animals
infused with glucose to obtain a chronic hyperglycemia (Jamison
et al., 2011). Hence, the paradoxical induction of glucagon
secretion is due to direct effects of hyperglycemia in the alpha-
cell (Knudsen et al., 2019) and it is exacerbated indirectly by loss
of beta-cells, when the inhibitory paracrine effect of insulin is lost.
A simple feedback model cannot adequately capture the two
effects of hyperglycemia underlying the paradoxical increase
of glucagon secretion (Wang et al., 2015), because it is
centered on negative control loops between glycemia and two
pancreatic hormones, insulin and glucagon. As a consequence,
the feedback model makes organismal hierarchies collapse. This
concerns all constraints from the second-order (as insulin and
glucagon), to the higher-order constraints– such as the intra-islet
interactions that regulate glucagon secretion, including beta-cells
constraining glucagon secretion by the alpha-cells. The more
orders of constraints are identified, the more the model flattens
the functional organization of the organism (see for instance
Röder et al., 2016, p. 5) the more the model loses explanatory
adequacy. In fact, the feedback loop is useful to depict the
situation in diabetes as long as the disease is seen as a problem due
to lack of insulin (type 1 diabetes, T1D) or to insulin resistance
(type 2 diabetes, T2D). However, since the discovery of the role
of beta-cells on suppressing glucagon secretion by alpha-cells, the
centrality of insulin deficiency on the genesis and maintenance of
diabetes was re-evaluated, if not contested. As a result, the role
of excess glucagon is given equal importance if not supremacy
over the classical insulin centered view (bi-hormonal hypothesis).
Intra-islet paracrine regulation of glucagon by the beta-cells, as
well as by paracrine secretion of additional pancreatic hormones
and by the nervous system are higher-order order constraints that
are not represented as such in the feedback model20.
As discussed in the previous Section, regulation consists of the
capacity to selectively modulate the first-order self-maintaining
regime in response to specific variations of the internal and
external environment, due to the action of a dynamically
decoupled dedicated control subsystem that is sensitive to these
variations. Regulation allows the new first-order regime to
cope with the changed environmental conditions and internal
requirements. Constraints exerted by alpha- and beta-cells from
the pancreas comply with this characterization of regulation, by
constituting a subsystem that is sensitive to specific conditions
and exerts second-order control upon first-order constraints in a
way that is dynamically decoupled from them. More specifically,
we have identified seven sets of processes, seven sets of associated
first-order constraints, and a regulatory subsystem endowed with
two sets of second-order constraints. Depending on the capacity
20Another interesting example of therapeutic effects that are not easily explained
by the feedback loop is the remission of T2D by bariatric surgery. Although this
procedure was originally used to reduce weight in obese patients, it was found
that it also induced remission of T2D. In particular, this procedure revealed the
importance of the small intestine in glucose homeostasis. Several hypotheses were
advanced on the importance of each of the components underlying remission,
from glucose and nutrient sensing (sensitive constraint) to incretin secretion (third
order constraint) (Laferrère, 2016). While these functions could be integrated into
a hierarchical organizational description, they would suffer from the same problem
of flattening in a feedback loop.
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of some of the constraints of the regulatory subsystem to sense
variations in the metabolic state of pancreatic cells, which in turn
is affected by the supply of glucose, the system can selectively
modulate the regime of first-order constraints: when perturbed
by food intake, it does so through insulin, resulting in an
increased production of glycogen from glucose; in the case of high
energy demands, through glucagon, resulting in an increased
production of glucose from glycogen. The overall result is the self-
maintenance of the organism in varying conditions, achieved in
particular through the homeostasis of glucose concentration in
the plasma. While models relying on feedback loops only describe
the relations between the variables involved in homeostasis,
models relying on organizational closure can also derive these
relations from the underlying functional organization of the
organism. It is for this reason that, we hold, the organizational
framework has a potentially higher explanatory power.
The above schema, however, focuses exclusively on
metabolism and, accordingly, is still the first step in a more
elaborate description. Many other, non-metabolic factors,
including the nervous system, the intestine, and adipose and
muscle tissues also participate in the modulation of insulin and
glucagon secretion in relation to other environmental or internal
conditions (Röder et al., 2016)21. This means that second-order
regulatory constraints acting on the first-order regime are not
at the top of the hierarchy but can themselves be modulated
by higher-order constraints belonging to regulatory subsystems
sensitive to different variables (Figure 2C). Unlike the feedback
model, the organizational framework can naturally handle these
additional regulatory subsystems by including in the closed
graph the pertinent processes and constraints, and by making
explicit the different orders involved. The procedure applied so
far to identify and integrate first- and second-order functional
constraints can be further iterated to obtain a richer and more
adequate representation of the biological organization involved
in the phenomenon under scrutiny.
DISCUSSION AND CONCLUSION
Let us compare the two different descriptions of glucose
regulation as represented in Figures 1, 2: feedback loops vs.
organizational closure.
The representation in terms of feedback loops – and more
generally in terms of single level networks – explains glucose
homeostasis by focusing on the values of three variables, i.e.,
the concentrations of glucose (glycemia), insulin and glucagon.
The relationships between these variables are determined by a set
of functional components, which are included in the system as
independent objects, i.e., as objects whose conditions of existence
do not depend on the dynamics they control. As a result, feedback
21The fact that alpha- and beta-cells are sensitive to their internal state rather than
directly to glucose, makes it possible for distinct processes (not directly dependent
on glucose) to coordinate different steps of the activation process of insulin and
glucagon secretion. For example “insulin release is stimulated by the so-called
cephalic phase, which represents the conditioned reflex of increased hormone
secretion, referred to as cephalic phase insulin response, even in the absence of
nutrients/glucose as a trigger, such as when anticipating a meal, to prepare the
organism to adequately respond to incoming nutrients”(Röder et al., 2016, p. 5).
loops only include those relations among components – usually
described as signals – that are relevant to explain the values of the
target variables.
The main motivation behind the adoption of the
organizational framework is radically different from that
underlying feedback loops. Rather than focusing only on
a specific relationship between variables, it also aims at
understanding glucose homeostasis as a manifestation, as
a consequence of the distinctive biological capacity of self-
maintenance and, in particular, of organisms’ capacity to manage
energetic resources. Accordingly, functional components
contribute to the maintenance of a biological organization
that, in turn, contributes to maintain their own conditions
of existence. In the organizational terminology, functional
components are subject to closure. Understanding glucose
homeostasis in light of biological self-maintenance leads to a
significant enrichment of the quantity and kinds of functional
objects and processes involved. In particular, we have emphasized
the crucial distinction between different orders of functionality,
each of them implying different kinds of constraints and
processes. The regulation of glucose concentrations and
metabolism is achieved through the coordinated activity of a
hierarchy of functional regimes, which seem to be overlooked by
descriptions appealing to feedback loops.
While feedback loops rely on the machine analogy,
organizational closure emphasizes the disanalogy. Most of
the differences between the two frameworks, we submit, derive
from this central epistemological divergence. But what is at stake
is not just a matter of difference. It is our contention that the
organizational framework possesses a higher explanatory power
than descriptions in terms of feedback loops, insofar as the
former can replace the latter, but not vice-versa. As we suggested
with the example of glucose regulation, the organizational
framework can explain the homeostasis of a variable as the result
of the functional and hierarchical complexity of an organism.
In contrast, a description in terms of feedback loops cannot
capture the functional complexity of the organization underlying
biological homeostasis. There are many ways to realize the
same feedback loop, and the organizational framework aims at
understanding how biological organisms achieve that goal in
each specific circumstance (e.g., through coupled processes, loops
involving one order of constraints, regulatory loops involving
second-order constraints, higher level regulatory loops including
third order constraints and so on and so forth) and explaining its
functional significance. In a word, we argue that organizational
models can explain all what feedback models explain, and more.
The higher explanatory power of the organizational
perspective has further implications, that allow going beyond
the weaknesses of feedback loops mentioned at the end of
Section “The Standard Representation of Glycemia Regulation:
The Feedback Loop.” A description of regulation in terms
of organizational closure, by placing it in the context of the
organism, enables the ascription of several functions to the
same component, or the ascription of a given function to a
set of distributed structures or even – to refer again to the
“device” that sets the normal range of a target variable – to
the organism as a whole. The different posture with respect to
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an engineering conception that describes a phenomenon by
appealing to a system of fixed components and localized and
univocal functional roles appears clearly here. Also, unlike the
feedback description, the organizational perspective fosters the
progressive integration of additional processes and functional
constraints into the description, insofar as its main explanandum
is not the homeostasis of a variable per se, but the capacity of
self-maintenance of the organism as a whole. In particular, it
encourages improving the description of a system by specifying
several hierarchical orders of regulatory constraints.
Another important implication, already evoked at the end of
Section “The Standard Representation of Glycemia Regulation:
The Feedback Loop,” is that the organizational framework leaves
room for variations in the regulation of glucose (as well as other
variables) and departures from a given range of homeostatic
values. The reason, again, is that glucose homeostasis is not a goal
in itself, but a means to achieve self-maintenance; accordingly,
an organism can vary its behavior as soon as the specific
internal and external conditions require an adaptive response,
be it a temporary or irreversible shift. The difference with
regulation in machines, which are designed for maintaining
a variable within a given range (deviations from the latter
being therefore conceived as an error), is blatant here. Lastly,
and symmetrically with respect to the previous point, the
understanding of homeostasis from an organicist perspective
opens the possibility of connecting homeostasis with biological
norms, and thus with judgments about health and disease, while
feedback loops cannot. Just as deviations from the normal range
are not necessarily bad, the maintenance of homeostasis is not
necessarily good: their biological significance depends on the
general state of the organisms and its adaptive needs. Fever
in response to infection is one of the best-known adaptive
responses, as is the stress response. The recent availability
of instrumentation to perform continuous glucose monitoring
also revealed that normoglycemic individuals (according to
standard clinical measurements) exhibit high interstitial glucose
concentration variability; their glucose concentrations may reach
prediabetic and diabetic ranges during a significant portion of the
monitored time. This interindividual variability also appears as
a response to standardized meals, thus suggesting that glucose
homeostasis within a specific range is not as “normal” as
previously thought (Hall et al., 2018). In this regard, it is useful to
think on the adaptive potential of interindividual variability. For
example, insulin resistance is considered by some as an adaptive
response that protects the cardiovascular tissues from nutrient-
induced injury, rather than the main culprit of the T2D syndrome
(Nolan et al., 2015).
Because of these implications, we argue that the organizational
framework is worth exploring. The representation of glycemia
regulation offered here constitutes what is sometimes called a
“proof of concept,” i.e., an illustration of how the framework
could apply to a specific biological phenomenon and how
it can be represented through diagrams22. Its epistemological
22As argued by Bechtel (2008), diagrams are an important component of scientific
reasoning, useful in order to represent how the phenomenon under study is
generated through the ‘well-orchestrated’ organization of the components that
role consists in fostering the elaboration of more precise
organizational models, which would make explicit many other
aspects, starting with the times scales and the topology of
the constraints involved in the control and regulation of the
relevant processes. One recent example of a model relying on
organizational principles is provided by the work of Montévil and
coworkers on mammary organogenesis (Montévil et al., 2016).
To be sure, the scientific fruitfulness of the organizational
framework can be adequately assessed (as is the case for any
theoretical proposal) only by looking at the quantity and quality
of the models that it could generate. Yet, the illustration
provided here has the merit of making explicit some guidelines
for elaborating models, which should focus – as discussed in
Section “Reinterpreting Glucose Regulation from Organizational
Principles” – on those objects that play a central role in the
organizational framework: processes, time scales, constraints,
constraint dependencies, closure and the hierarchy of functional
orders. It also shows that the organizational framework tends
to promote the integration into a single model of experimental
data that are usually obtained and exploited separately by
different experimental groups and scientific communities (see
also Veloso, 2017). Accordingly, the framework can make an
important contribution in overcoming the compartmentalization
that sometimes characterizes experimental research. Conversely,
the inherent tendency to integrate data into organism-centered
models may induce the search of new experimental data required
to “bridge the gap” between aspects and phenomena that have
never been treated and interpreted jointly.
The proof of concept provided in this study also fulfills
another epistemological function, which consists of putting some
of the challenges that an organization-centered modeling strategy
has to face into the foreground.
One challenge consists of integrating a variety of processes,
interactions and associated functional constraints realizing
organizational closure, by making their topological and
quantitative relations explicit. Insofar as they would explore new
ways of looking at biological organisms, organizational models
may require developing original formal and mathematical
tools. Moreover, the various levels and orders that constitute
the hierarchical organization of the organism should be
discriminated and integrated. However, the task of drawing
the functional boundaries of a given regulatory subsystem,
by identifying both its sensitive and higher-order constraints,
may prove to be difficult to achieve in some cases. What is at
stake here is the specific nature of biological organisms, whose
functional organization is the result of an ontogenetic process
(instead of an assemblage of pre-existing parts, as in machines)
and an evolutionary history.
The organizational framework also faces the reciprocal
challenge vis-à-vis complexity. A satisfactory model does not
need to include all the details about the processes and constraints
at play in the organism: a trade-off between precision and
comprehensiveness must be found. The proof of concept
participate in it. Diagrams are needed precisely to develop a reasoning that
captures both the operations performed by the parts and the relationship between
these operations.
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presented here shows that an organizational framework can
provide theoretical guidelines for locating a target phenomenon
in the overall organization, and for removing dispensable aspects.
The organizational diagram given above, for instance, focuses
on various constraints that play a direct role in the regulation
of glycemia and, in turn, neglect other constraints involved in
the metabolism. The possibility of simultaneously detailing some
functional aspects while bracketing others allows the framework
to make the model more relevant with regards to the specific
phenomenon under scrutiny, while maintaining the general
characterization of closure. More precisely, the fact of detailing
or neglecting specific aspects is achieved by “zooming” in or
out when describing the constraints and the processes on which
they act. In the above diagram, for instance, constraints such as
insulin, glucagon, alpha- and beta-cells and their target processes
are described in a more detailed way when compared to the
digestive system or the vascular system. Also, the framework
allows neglecting details at some level of description, when it
focuses on processes and functions located at other levels. For
example, when considering a tissue as a constraint performing a
function (and not as a collection of cells), one may concentrate
on collective aspects like cell junctions, cell adhesion to the
substrate and cell–matrix interactions, and ignore – at least to
some extent –intracellular aspects and components.
As a result, even though the organizational diagram includes
more objects than the feedback loop, it succeeds in providing a
tractable and useful description of biological complexity. Most
of the time, the decision about which functional aspects should
be detailed and which one should be bracketed depends on the
phenomenon being considered and the explanatory aim of the
model. Yet, the organizational framework might also be able to
elaborate some general guidelines in this respect: exploring this
question could elicit a fundamental epistemological discussion on
modeling practices from an organicist perspective.
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